• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米纤维血管移植物在大小动物模型中的不同降解速率。

Different degradation rates of nanofiber vascular grafts in small and large animal models.

机构信息

Division of Cardiac Surgery, Johns Hopkins Hospital, Baltimore, MD.

Center for Regenerative Medicine, Nationwide Children's Hospital, Columbus, OH.

出版信息

J Tissue Eng Regen Med. 2020 Feb;14(2):203-214. doi: 10.1002/term.2977. Epub 2020 Jan 22.

DOI:10.1002/term.2977
PMID:31756767
Abstract

Nanofiber vascular grafts have been shown to create neovessels made of autologous tissue, by in vivo scaffold biodegradation over time. However, many studies on graft materials and biodegradation have been conducted in vitro or in small animal models, instead of large animal models, which demonstrate different degradation profiles. In this study, we compared the degradation profiles of nanofiber vascular grafts in a rat model and a sheep model, while controlling for the type of graft material, the duration of implantation, fabrication method, type of circulation (arterial/venous), and type of surgery (interposition graft). We found that there was significantly less remaining scaffold (i.e., faster degradation) in nanofiber vascular grafts implanted in the sheep model compared with the rat model, in both the arterial and the venous circulations, at 6 months postimplantation. In addition, there was more extracellular matrix deposition, more elastin formation, more mature collagen, and no calcification in the sheep model compared with the rat model. In conclusion, studies comparing degradation of vascular grafts in large and small animal models remain limited. For clinical translation of nanofiber vascular grafts, it is important to understand these differences.

摘要

纳米纤维血管移植物已被证明可以通过体内支架的逐渐生物降解,在体内产生由自体组织构成的新生血管。然而,许多关于移植物材料和生物降解的研究都是在体外或小动物模型中进行的,而不是在大动物模型中进行的,因为大动物模型显示出不同的降解特征。在这项研究中,我们比较了纳米纤维血管移植物在大鼠模型和绵羊模型中的降解特征,同时控制了移植物材料的类型、植入时间、制造方法、循环类型(动脉/静脉)和手术类型(间置移植物)。我们发现,在植入后 6 个月,无论是在动脉循环还是静脉循环中,与大鼠模型相比,绵羊模型中的纳米纤维血管移植物的支架残留量明显较少(即降解速度更快)。此外,与大鼠模型相比,绵羊模型中存在更多的细胞外基质沉积、更多的弹性蛋白形成、更成熟的胶原,且没有发生钙化。总之,关于大动物和小动物模型中血管移植物降解的比较研究仍然有限。对于纳米纤维血管移植物的临床转化,了解这些差异非常重要。

相似文献

1
Different degradation rates of nanofiber vascular grafts in small and large animal models.纳米纤维血管移植物在大小动物模型中的不同降解速率。
J Tissue Eng Regen Med. 2020 Feb;14(2):203-214. doi: 10.1002/term.2977. Epub 2020 Jan 22.
2
Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model.基于无细胞纳米纤维聚己内酯/壳聚糖支架构建的组织工程小口径动脉血管移植物在绵羊模型中的研究
PLoS One. 2016 Jul 28;11(7):e0158555. doi: 10.1371/journal.pone.0158555. eCollection 2016.
3
Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model.使用 3D 打印在绵羊模型中进行患者特异性无细胞纳米纤维组织工程血管移植物的临床前研究。
J Thorac Cardiovasc Surg. 2017 Apr;153(4):924-932. doi: 10.1016/j.jtcvs.2016.10.066. Epub 2016 Nov 14.
4
Development of small diameter nanofiber tissue engineered arterial grafts.小直径纳米纤维组织工程动脉移植物的研发。
PLoS One. 2015 Apr 1;10(4):e0120328. doi: 10.1371/journal.pone.0120328. eCollection 2015.
5
Targeted imaging of matrix metalloproteinase activity in the evaluation of remodeling tissue-engineered vascular grafts implanted in a growing lamb model.在评估植入生长中的羔羊模型的组织工程血管移植物重塑过程中对基质金属蛋白酶活性进行靶向成像。
J Thorac Cardiovasc Surg. 2014 Nov;148(5):2227-33. doi: 10.1016/j.jtcvs.2014.05.037. Epub 2014 May 21.
6
Well-organized neointima of large-pore poly(L-lactic acid) vascular graft coated with poly(L-lactic-co-ε-caprolactone) prevents calcific deposition compared to small-pore electrospun poly(L-lactic acid) graft in a mouse aortic implantation model.在小鼠主动脉植入模型中,与小孔径电纺聚(L-乳酸)移植物相比,涂覆聚(L-乳酸-共-ε-己内酯)的大孔径聚(L-乳酸)血管移植物具有组织良好的新生内膜,可防止钙化沉积。
Atherosclerosis. 2014 Dec;237(2):684-91. doi: 10.1016/j.atherosclerosis.2014.09.030. Epub 2014 Oct 17.
7
Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques.利用骨髓来源的血管细胞构建自体组织工程静脉导管:细胞采集与接种技术的优化
J Pediatr Surg. 2007 Jan;42(1):198-202. doi: 10.1016/j.jpedsurg.2006.09.054.
8
Electrospun nanofiber scaffold for vascular tissue engineering.用于血管组织工程的静电纺纳米纤维支架。
Mater Sci Eng C Mater Biol Appl. 2021 Oct;129:112373. doi: 10.1016/j.msec.2021.112373. Epub 2021 Aug 14.
9
Vascular Tissue Engineering: Effects of Integrating Collagen into a PCL Based Nanofiber Material.血管组织工程:将胶原蛋白整合到基于 PCL 的纳米纤维材料中的影响。
Biomed Res Int. 2017;2017:9616939. doi: 10.1155/2017/9616939. Epub 2017 Aug 28.
10
The effect of pore diameter on neo-tissue formation in electrospun biodegradable tissue-engineered arterial grafts in a large animal model.孔径对大型动物模型中电纺可生物降解组织工程动脉移植物新组织形成的影响。
Acta Biomater. 2020 Oct 1;115:176-184. doi: 10.1016/j.actbio.2020.08.011. Epub 2020 Aug 18.

引用本文的文献

1
Biomechanical enhancement in rotator cuff repairs: the impact of innovative nanofiber technology.肩袖修复中的生物力学增强:创新纳米纤维技术的影响。
JSES Int. 2024 Sep 10;9(1):116-122. doi: 10.1016/j.jseint.2024.08.203. eCollection 2025 Jan.
2
Leveraging printability and biocompatibility in materials for printing implantable vessel scaffolds.利用材料的可印刷性和生物相容性来打印可植入血管支架。
Mater Today Bio. 2024 Nov 23;29:101366. doi: 10.1016/j.mtbio.2024.101366. eCollection 2024 Dec.
3
Pair of Functional Polyesters That Are Photo-Cross-Linkable and Electrospinnable to Engineer Elastomeric Scaffolds with Tunable Structure and Properties.
可光交联和静电纺丝的功能聚酯对,用于构建具有可调结构和性能的弹性支架。
ACS Appl Bio Mater. 2024 Feb 19;7(2):863-878. doi: 10.1021/acsabm.3c00894. Epub 2024 Jan 11.
4
Comparison of the Patency and Regenerative Potential of Biodegradable Vascular Prostheses of Different Polymer Compositions in an Ovine Model.不同聚合物组成的可生物降解血管假体在羊模型中的通畅性和再生潜力比较。
Int J Mol Sci. 2023 May 10;24(10):8540. doi: 10.3390/ijms24108540.
5
Strategies to counteract adverse remodeling of vascular graft: A 3D view of current graft innovations.对抗血管移植物不良重塑的策略:当前移植物创新的三维视角。
Front Bioeng Biotechnol. 2023 Jan 10;10:1097334. doi: 10.3389/fbioe.2022.1097334. eCollection 2022.
6
Controlled and Synchronised Vascular Regeneration upon the Implantation of Iloprost- and Cationic Amphiphilic Drugs-Conjugated Tissue-Engineered Vascular Grafts into the Ovine Carotid Artery: A Proteomics-Empowered Study.将伊洛前列素和阳离子两亲性药物共轭的组织工程血管移植物植入绵羊颈动脉后的可控同步血管再生:一项蛋白质组学助力的研究
Polymers (Basel). 2022 Nov 26;14(23):5149. doi: 10.3390/polym14235149.
7
Acellular Tissue-Engineered Vascular Grafts from Polymers: Methods, Achievements, Characterization, and Challenges.基于聚合物的无细胞组织工程血管移植物:方法、成果、表征及挑战
Polymers (Basel). 2022 Nov 9;14(22):4825. doi: 10.3390/polym14224825.
8
Small Diameter Cell-Free Tissue-Engineered Vascular Grafts: Biomaterials and Manufacture Techniques to Reach Suitable Mechanical Properties.小直径无细胞组织工程血管移植物:实现合适力学性能的生物材料与制造技术
Polymers (Basel). 2022 Aug 23;14(17):3440. doi: 10.3390/polym14173440.
9
Vascular Repair by Grafting Based on Magnetic Nanoparticles.基于磁性纳米颗粒的移植血管修复术。
Pharmaceutics. 2022 Jul 8;14(7):1433. doi: 10.3390/pharmaceutics14071433.
10
Marker-Independent Monitoring of and Degradation of Supramolecular Polymers Applied in Cardiovascular Tissue Engineering.心血管组织工程中应用的超分子聚合物的标记物独立监测与降解
Front Cardiovasc Med. 2022 May 17;9:885873. doi: 10.3389/fcvm.2022.885873. eCollection 2022.